This study tests whether adding an SGLT2 inhibitor to standard ARB therapy better reduces protein in the urine (a sign of kidney damage) in diabetic patients without high blood pressure. Sixty adults aged 30-60 with diabetes and microalbuminuria will receive either ARBs alone or …
Phase: PHASE2, PHASE3 • Sponsor: Dr Mudassar Saeed Pansota • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC